CR10053A - - Google Patents
Info
- Publication number
- CR10053A CR10053A CR10053A CR10053A CR10053A CR 10053 A CR10053 A CR 10053A CR 10053 A CR10053 A CR 10053A CR 10053 A CR10053 A CR 10053A CR 10053 A CR10053 A CR 10053A
- Authority
- CR
- Costa Rica
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA05013220A MXPA05013220A (es) | 2005-12-06 | 2005-12-06 | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10053A true CR10053A (pt) | 2008-08-06 |
Family
ID=38123117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10053A CR10053A (pt) | 2005-12-06 | 2008-06-06 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1958636A1 (pt) |
| BR (1) | BRPI0619616A2 (pt) |
| CR (1) | CR10053A (pt) |
| EC (1) | ECSP088507A (pt) |
| MX (1) | MXPA05013220A (pt) |
| WO (1) | WO2007067027A1 (pt) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
| US20040147564A1 (en) * | 2003-01-29 | 2004-07-29 | Rao Vinay U. | Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
| TWI339586B (en) * | 2003-10-31 | 2011-04-01 | Takeda Chemical Industries Ltd | Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester |
-
2005
- 2005-12-06 MX MXPA05013220A patent/MXPA05013220A/es not_active Application Discontinuation
-
2006
- 2006-06-23 WO PCT/MX2006/000060 patent/WO2007067027A1/es not_active Ceased
- 2006-06-23 BR BRPI0619616-0A patent/BRPI0619616A2/pt not_active Application Discontinuation
- 2006-06-23 EP EP06769371A patent/EP1958636A1/en not_active Withdrawn
-
2008
- 2008-06-06 CR CR10053A patent/CR10053A/xx not_active Application Discontinuation
- 2008-06-06 EC EC2008008507A patent/ECSP088507A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP088507A (es) | 2008-07-30 |
| WO2007067027A1 (es) | 2007-06-14 |
| MXPA05013220A (es) | 2007-06-05 |
| EP1958636A1 (en) | 2008-08-20 |
| BRPI0619616A2 (pt) | 2011-10-04 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |